IN FOCUS FEATURE
Metrics' Greenville Expansion Complete
FROM OUR WEB SITE
North Carolina Bioscience
Companies and Employees
From Our Web Site
Durham's Argos Therapeutics Gets $35.2M Infusion
The Duke University spinout receives funding to study potential disease treatments based on the cells that switch the immune system on and off.
Aldagen Lands $18.4M in New Venture Capital
Aldagen of Durham lands $18.4M in new funding as clinical trials proceed.
UNC, Hamner Institutes Announce Partnership
The University of North Carolina-Chapel Hill and The Hamner Institutes for Health Sciences have signed a collaborative agreement to accelerate basic, translational research.
AlphaVax Reports Positive Trial Data
AlphaVax Inc. has reported initial positive results from a Phase I clinical trial of a vaccine for a virus that causes drastic harm to infants and transplant recipients.
Wake Forest Regenerative Medicine Group Shares $42.5M Grant
Dr. Anthony Atala's group at Wake Forest will work with the U.S. Army and another academic research group to develop treatments that heal wounds sustained in battle.
Aldagen Begins Phase III Trial for Cord Blood Transplant Drug
The Durham-based company is testing a drug to improve cord blood transplants that treat inherited pediatric metabolic diseases.
In Focus
Metrics' Greenville Expansion Complete
A broader spectrum of services was the goal when Metrics began expansion of its Greenville office.
Now that the 47,000-square-foot, $18 million expansion is complete, the company can better support all stages of clinical trials and development for pharmaceutical companies.
The company added four new analytical laboratories, manufacturing space, stable environment storage areas and a microbiology laboratory. The company's current staff of 225 is expected to grow by more than 20 percent.
The growth and investment over time earned Metrics the Pitt County Development Commision's Industry of the Year award in March. It's also been recognized with business champion awards from Business Leader and Wake Technical Community College.
Read more about Metrics expansion.
News from Other Sites
Not Your Run-of-the-Mill Bandage
Imagine a bandage that actually helps stop bleeding. Entegrion, a Research Triangle Park company, is making it happen.
From Textile World
LAAMScience Grew From a Germ of an Idea
Raleigh-based LAAMScience sits on the brink of FDA approval for its product - specially treated fabric that kills viruses on contact. The fabric can be used to make face masks used in hospitals and other healthcare settings.
From the (Raleigh) News and Observer
UNC-CH, Hamner Institutes Team Up for Research, Commercialization
UNC provides the research and The Hamner adds the business expertise in this partnership to commercialize more products.
From WRAL LocalTechWire
Core Lab at Research Campus Continues Progress
The main laboratory facility at the North Carolina Research Campus in Kannapolis is almost ready for its one-of-a-kind nuclear magnetic resonance spectrometer, and the campus around it is taking shape as well.
From the Salisbury Post
Community Watch
Research Triangle Park-based Quintiles Transnational has appointed three new practice leaders and a business development head as part of its expanding Quintiles Consulting business.
- John Doyle, Dr. P.H., M.P.H., joined the firm as practice leader, market access, U.S.
- Adrian McKemey, Ph.D., was hired as practice leader, product development and commercialization, U.S.
- Jim Featherstone, Ph.D., joined the firm as practice leader, regulatory and quality and product development and commercialization, Europe.
- Matt Eberhart, MBA, was hired as vice president, business development.
Please send Community Watch items to Jim Shamp.
Save the Date
May 9
Biofuels Center Opening
(Oxford)
May 19-20
Biotech 2008
(Winston-Salem)
June 17-20
BIO 2008 Conference
NC Pavilion Sponsorship
(San Diego)
Dec. 4-5
SE Bio Investor Forum
(Palm Beach, Fla.)
View our complete listing of events across North Carolina.
This newsletter was sent Thursday, Apr. 24, 2008. For the latest North Carolina biotechnology industry headlines, please visit the news section of our Web site.
Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.